Alessandro Dinoto Selected Research

Therapeutics

1/2022

Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Dinoto Research Topics

Disease

6	Multiple Sclerosis 10/2023 - 11/2020
5	Neoplasms (Cancer) 02/2024 - 03/2022
5	Neuromyelitis Optica (Devic's Disease) 01/2024 - 01/2022
4	Infections 01/2024 - 01/2022
4	COVID-19 01/2024 - 01/2022
4	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 01/2022
3	Encephalitis (Encephalitis, Rasmussen) 10/2023 - 10/2020
2	Leukocytosis (Pleocytosis) 10/2023 - 10/2023
2	Nervous System Diseases (Neurological Disorders) 03/2023 - 07/2022
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 12/2022
2	Glioma (Gliomas) 07/2022 - 10/2020
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021 - 12/2018
2	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 10/2020 - 05/2019
1	Disease Progression 02/2024
1	Movement Disorders (Movement Disorder) 02/2024
1	Coronavirus Infections 01/2024
1	Virus Diseases (Viral Diseases) 01/2024
1	Brain Diseases (Brain Disorder) 10/2023
1	Motor Disorders 03/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Muscular Diseases (Myopathy) 01/2023
1	Neutropenia 12/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2022
1	Lymphoma (Lymphomas) 03/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Inflammation (Inflammations) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Merkel Cell Carcinoma 01/2022
1	Oculomotor Nerve Diseases (Oculomotor Nerve Palsy) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Gait Ataxia 01/2022
1	Autoimmune Diseases of the Nervous System 01/2022
1	Spasm (Spasms) 12/2021
1	Vomiting 01/2021
1	Transverse Myelitis (Necrotizing Myelitis) 01/2021
1	Adenocarcinoma 01/2021
1	Hiccup (Hiccups) 01/2021
1	Fatigue 11/2020
1	Seizures (Absence Seizure) 10/2020
1	Neurobehavioral Manifestations 10/2020
1	Motor Neuron Disease (Primary Lateral Sclerosis) 05/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2019
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 12/2018

Drug/Important Bio-Agent (IBA)

9	AntibodiesIBA 01/2024 - 05/2019
8	Myelin-Oligodendrocyte GlycoproteinIBA 01/2024 - 01/2022
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2022
5	Immunoglobulin G (IgG)IBA 01/2024 - 11/2022
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2022
3	AutoantibodiesIBA 10/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2023
2	Immunoglobulin M (IgM)IBA 01/2024 - 01/2023
2	Complement System Proteins (Complement)IBA 10/2023 - 01/2023
2	Rituximab (Mabthera)FDA Link 12/2022 - 10/2020
2	AntigensIBA 07/2022 - 03/2022
2	Leucine (L-Leucine)FDA Link 07/2022 - 10/2020
2	CytokinesIBA 01/2022 - 01/2022
2	Bortezomib (Velcade)FDA Link 01/2022 - 01/2021
1	SteroidsIBA 02/2024
1	Nucleocapsid ProteinsIBA 01/2024
1	Immunoglobulin A (IgA)IBA 01/2024
1	GadoliniumIBA 10/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	Myelin-Associated GlycoproteinIBA 01/2023
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2023
1	ocrelizumabIBA 12/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2022
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 12/2022
1	COVID-19 VaccinesIBA 07/2022
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 07/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Natalizumab (Tysabri)FDA Link 01/2022
1	NivolumabIBA 01/2022
1	Basiliximab FDA Link 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	Dimethyl FumarateIBA 01/2022
1	daratumumabIBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	tofacitinibIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	avelumabIBA 01/2022
1	ChemokinesIBA 01/2022
1	Aquaporins (Water Channels)IBA 01/2022
1	nabiximols (Sativex)IBA 12/2021
1	Botulinum Toxins (Botulinum Toxin)IBA 12/2021
1	N-Methylaspartate (NMDA)IBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Ketamine FDA LinkGeneric 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	perampanelIBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 11/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 10/2020
1	Monoclonal AntibodiesIBA 10/2020

Therapy/Procedure

7	Immunotherapy 02/2024 - 01/2021
1	Duration of Therapy 01/2022
1	Therapeutics 01/2022
1	Injections 12/2021
1	Radiotherapy 01/2021
1	Contraindications 11/2020